From: The crucial regulatory role of type I interferon in inflammatory diseases
Study | Types of IFN-I | Target of action | Stimuli | Experimental models | Effect | Diseases |
---|---|---|---|---|---|---|
Dean et al. 2021 [56] | IFN-I | IFN-I | COVID-19 | Peripheral blood of COVID-19 patients | Duality | Viral infection |
Nocito et al. 2020 [57] | IFN-α | IFN-α | Captopril | MRL/lpr and MRL/wt female mice | Anti-inflammatory | SLE |
Kitamura et al. 2020 [58] | IFN-α | IFN-α | Experimental radiation | C57BL/6 mice | Pro-inflammatory | Esophagitis |
Fernandez-Sendin et al. 2020 [59] | IFN-α | IFN-α | Apolipoprotein AI mimetic peptide L37pA | C57BL/6 mice | Anti-inflammatory | Viral infection |
Chen et al. 2022 [60] | IFN-α | IFN-α | A. cinnamomea | BHK-21 cells | Anti-inflammatory | Viral infection |
Zhang et al. 2022 [61] | IFN-β | IFN-β | PON1 | PAM | Pro-inflammatory | Viral infection |
Li et al. 2020 [62] | IFN-β | IFN-β | MiR-30a | HeLa cells and 293 T cells | Pro-inflammatory | Viral infection |
Jang et al. 2018 [63] | IFN-β | IFN-β | Enhanced IFN-β | Human tissue from a patient with sinusitis | Pro-inflammatory | Sinusitis |
Cook et al. 2019 [64] | IFN-α and IFN-β | IFN-α and IFN-β | CHIKV | C57BL/6 mice | Anti-inflammatory | Viral infection |
Lei et al. 2021 [65] | IFN-α and IFN-β | IFN-β | NRF2 | mtDNA mutant mice | Pro-inflammatory | Not given |
Arimori et al. 2013 [66] | IFN-α and IFN-β | IFNAR | IFNAR KO | IFNAR KO mouse models | Pro-inflammatory | Viral infection |
Sontheimer et al. 2017 [67] | IFN-α and IFN-β | IFNAR | UVB and IFNAR KO | IFNAR KO mouse models | Pro-inflammatory | SLE |
Ansar et al. 2021 [68] | IFN-α | IFNAR | RS | BAL from mice | Anti-inflammatory | Viral infection |
Cagliani et al. 2019 [69] | IFN-α | IFNAR | IFNAR1-Ab | C57BL6 mice | Anti-inflammatory | HS |
D'Souza et al. 2021 [70] | IFN-α and IFN-β | IFNAR | MO-IFN | C57BL/6 mice | Pro-inflammatory | Not given |
Chan et al. 2020 [71] | IFN-α and IFN-β | IFNAR | Activation of IFN/ IFNAR axis | Mouse primary adipocytes | Pro-inflammatory | Obesity |
Minayoshi et al. 2018 [72] | IFN-α and IFN-β | IFNAR | Man-HSA(D494N)-IFNα2b | C57BL/6 mice | Anti-inflammatory | Hepatitis |
Tanaka et al. 2012 [73] | IFN-α and IFN-β | STAT1 | Damaged STAT1 | Gingival tissue samples | Pro-inflammatory | Periodontitis |
Nataraja et al. 2022 [74] | IFN-α | STAT1 | GILZ | C57BL/6 mice | Anti-inflammatory | SLE |
Chen et al. 2022 [75] | IFN-α | STAT1 | Menthone | CIA mouse models | Anti-inflammatory | RA |
Hu et al. 2022 [76] | IFN-β | STAT1 | RUNX1 | A549 cells | Anti-inflammatory | Viral infection |
Yang et al. 2020 [77] | IFN-α and IFN-β | STAT1 | hsa_circ_0060450 | Peripheral blood of T1DM patients and healthy controls | Anti-inflammatory | T1DM |
Gothe et al. 2022 [78] | IFN-α | STAT2 | STAT2 deficiency | pluripotent stem cell-derived macrophages | Pro-inflammatory | Not given |
Wilson et al. 2019 [79] | IFN-α and IFN-β | STAT2 | S. typhimurium | C57BL/6 mice | Pro-inflammatory | Bacterial infection |
Shen et al. 2020 [80] | IFN-β | STAT2 | PCV3 Cap | HEK 293 T and PK15 cells | Pro-inflammatory | Viral infection |
Kozela et al. 2010 [81] | IFN-β | STAT3 | CBD | BV-2 murine microglial cell line | Anti-inflammatory | Not given |
Racicot et al. 2016 [82] | IFN-β | STAT3 | Upregulated STAT3 | Human trophoblasts SW.71 and C57BL/6 mice | Pro-inflammatory | Placental inflammation |
Febvre-James et al. 2018 [83] | IFN-β | JAK | Ruxolitinib | PBMCs | Anti-inflammatory | Not given |
Klopfenstein et al. 2021 [84] | IFN-β | JAK and STAT | MRSA | C57BL/6 mice | Pro-inflammatory | Bacterial infection |
Hadjadj et al. 2020 [85] | IFN-α and IFN-β | JAK and STAT1 | COVID-19 | sera from COVID-19 patients | Anti-inflammatory | Viral infection |
Stefan et al. 2017 [86] | IFN-α and IFN-β | IL-10R | S. typhimurium | C57BL/6 mice | Pro-inflammatory | Salmonella colitis |
Qu et al. 2015 [87] | IFN-α and IFN-β | MCPIP-1 and miR-146a | IFN-α and IFN-β | THP-1 cells | Pro-inflammatory | SLE |
Zhang et al. 2015 [88] | IFN-α and IFN-β | ISG15 | USP18 | Human blood sample cells | Pro-inflammatory | Not given |